Table 1.
Cohort 1 (n = 595) | Cohort 2 (n = 260) | |
---|---|---|
Gender, n (%) | ||
Male | 113 (19 %) | 65 (25 %) |
Female | 482 (81 %) | 195 (75 %) |
Age, years | ||
Mean (SD) | 40.5 (14.2) | 37 (14) |
Median | 39 | 33 |
Range | 18–74 | 17–74 |
Duration of condition, years | ||
Mean (SD) | 27.5 (14.1) | Na. |
Median | 25 | Na. |
Range | 2–69 | Na. |
Body are affected | ||
Heada | 129 (22 %) | 24 (9 %) |
Axillaa | 54 (9 %) | 28 (11 %) |
General | 130 (22 %) | 56 (22 %) |
Axilla, palms, feet | 158 (27 %) | 73 (28 %) |
Palms and feet | 124 (21 %) | 79 (30 %) |
Co-morbidityb | ||
Menopausal complaints | 61 (10 %) | 16 (6.2 %) |
Diabetes | 30 (5 %) | 11 (4.2 %) |
Hypertension | 47 (8 %) | 29 (11.2 %) |
Neurological disorders | 64 (11 %) | 30 (11.5 %) |
Thyroid disorders | 66 (11 %) | 13 (5 %) |
Employment status | ||
Employed | 380 (64 %) | 160 (61.5 %) |
Unemployed | 107 (18 %) | 37 (14.2 %) |
Retired | 70 (12 %) | 21 (8.1 %) |
Full-time student | 30 (6 %) | 42 (16.2 %) |
Country | ||
USA | 559 | 142 (54.6 %) |
Canada | 36 | 11 (4.2 %) |
Australia | Na. | 11 (4.2 %) |
UK | Na. | 73 (28.1 %) |
Other countries | Na. | 23 (9 %) |
aThe classification of the body site of hyperhidrosis reflects the predominant area of sweating
bPatients were asked to choose from a list of six conditions including other, to complete statement “I have problems with…”
Na not available